204 related articles for article (PubMed ID: 31392348)
21. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
[TBL] [Abstract][Full Text] [Related]
22. The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.
Faridounnia M; Wienk H; Kovačič L; Folkers GE; Jaspers NG; Kaptein R; Hoeijmakers JH; Boelens R
J Biol Chem; 2015 Aug; 290(33):20541-55. PubMed ID: 26085086
[TBL] [Abstract][Full Text] [Related]
23. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Bergstralh DT; Sekelsky J
Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
[TBL] [Abstract][Full Text] [Related]
24. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
[TBL] [Abstract][Full Text] [Related]
25. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
[TBL] [Abstract][Full Text] [Related]
26. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
Croteau DL; Peng Y; Van Houten B
DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
[TBL] [Abstract][Full Text] [Related]
28. Human HMGB1 directly facilitates interactions between nucleotide excision repair proteins on triplex-directed psoralen interstrand crosslinks.
Lange SS; Reddy MC; Vasquez KM
DNA Repair (Amst); 2009 Jul; 8(7):865-72. PubMed ID: 19446504
[TBL] [Abstract][Full Text] [Related]
29. Human XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks.
Thoma BS; Wakasugi M; Christensen J; Reddy MC; Vasquez KM
Nucleic Acids Res; 2005; 33(9):2993-3001. PubMed ID: 15914671
[TBL] [Abstract][Full Text] [Related]
30. Interstrand cross-links induce DNA synthesis in damaged and undamaged plasmids in mammalian cell extracts.
Li L; Peterson CA; Lu X; Wei P; Legerski RJ
Mol Cell Biol; 1999 Aug; 19(8):5619-30. PubMed ID: 10409751
[TBL] [Abstract][Full Text] [Related]
31. The formation of UV-induced chromosome aberrations involves ERCC1 and XPF but not other nucleotide excision repair genes.
Chipchase MD; Melton DW
DNA Repair (Amst); 2002 Apr; 1(4):335-40. PubMed ID: 12509251
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
[TBL] [Abstract][Full Text] [Related]
33. Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.
Takahata C; Masuda Y; Takedachi A; Tanaka K; Iwai S; Kuraoka I
Carcinogenesis; 2015 Aug; 36(8):841-51. PubMed ID: 26025908
[TBL] [Abstract][Full Text] [Related]
34. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
35. RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks.
Abdullah UB; McGouran JF; Brolih S; Ptchelkine D; El-Sagheer AH; Brown T; McHugh PJ
EMBO J; 2017 Jul; 36(14):2047-2060. PubMed ID: 28607004
[TBL] [Abstract][Full Text] [Related]
36. Removal of reactive oxygen species-induced 3'-blocked ends by XPF-ERCC1.
Fisher LA; Samson L; Bessho T
Chem Res Toxicol; 2011 Nov; 24(11):1876-81. PubMed ID: 22007867
[TBL] [Abstract][Full Text] [Related]
37. ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patients.
Apelt K; White SM; Kim HS; Yeo JE; Kragten A; Wondergem AP; Rooimans MA; González-Prieto R; Wiegant WW; Lunke S; Flanagan D; Pantaleo S; Quinlan C; Hardikar W; van Attikum H; Vertegaal ACO; Wilson BT; Wolthuis RMF; Schärer OD; Luijsterburg MS
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33315086
[TBL] [Abstract][Full Text] [Related]
38. SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.
Zhang H; Chen Z; Ye Y; Ye Z; Cao D; Xiong Y; Srivastava M; Feng X; Tang M; Wang C; Tainer JA; Chen J
Nucleic Acids Res; 2019 Nov; 47(19):10181-10201. PubMed ID: 31495888
[TBL] [Abstract][Full Text] [Related]
39. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
[TBL] [Abstract][Full Text] [Related]
40. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
De Silva IU; McHugh PJ; Clingen PH; Hartley JA
Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
